missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human CCL3L1/LD78 beta
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marca: R&D Systems™ 509-MI-025/CF
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
The Recombinant Human CCL3L1/MIP-1 alpha Isoform LD78 beta is derived from E. coli. The Recombinant Human CCL3L1/MIP-1 alpha Isoform LD78 beta has been validated for the following applications: Bioactivity.Especificaciones
| Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA. | |
| 7.8 kDa | |
| 25μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
| 6349 | |
| CCL3L1/MIP-1 alpha Isoform LD78 beta | |
| E. coli-derived human CCL3L1/MIP-1 alpha Isoform LD78 beta protein Ala24-Ala93 | |
| Unconjugated | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido